Stockreport

ImmunityBio announces results from Anktiva clinical program [Yahoo! Finance]

ImmunityBio, Inc.  (IBRX) 
PDF Across 151 patients spanning first-, second-, and later-line disease, Anktiva demonstrated statistically significant immune restoration and a consistent association betw [Read more]